期刊文献+

米氮平与阿米替林治疗抑郁症的对照研究 被引量:2

A Contrast Study of Mirtazapine and Amitriptyline in Treating Depression
下载PDF
导出
摘要 目的比较米氮平与阿米替林治疗抑郁症的疗效和不良反应。方法应用米氮平和阿米替林治疗抑郁症各30例,应用汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)进行评定,并进行临床疗效比较。结果米氮平与阿米替林治疗后HAMD、HAMA分值均显著下降,两组间减分比较,差异无显著性,米氮平不良反应发生率明显少于阿米替林。结论米氮平治疗抑郁症疗效与阿米替林相当,前者不良反应较轻,值得推广。 Objective To compare the curative effect and the side effect of mirtazapine and amitriptyline in treating depression. Methods 60 cases with depression were divided into 2 groups : mirtazapine group and amitriptyline group, 30 cases in each ; HAMD Scale and HAMA Scale were applied in evaluation and curative effect comparison. Results The scores of HAMD and HAMA in both groups decreased significantly with no obvious difference while the occurrence of side effect in mirtazapine group was much lower than that in amitriptyline group. Conclusions Mirtazapine and amitriptyline have the same effect in treating depression; mirtazapine cuases slight side effect and is worthy of wide application.
作者 谢玉荣
出处 《西南军医》 2010年第2期238-239,共2页 Journal of Military Surgeon in Southwest China
关键词 抑郁症 米氮平 阿米替林 depression mirtazapine amitriptyline
  • 相关文献

参考文献4

二级参考文献30

  • 1郭平,郭华,贾金鼎.米氮平和氯米帕明维持治疗抑郁症对照观察[J].临床精神医学杂志,2005,15(3):152-153. 被引量:18
  • 2[1]Do Boer t, Ruit GSF, Berendsen HHG. The alph αa selective adrenoceptor antagonist Org 3770 (mirtazapine, Remeron) enhances noradrenergic and serotonergic transmission. Hum Psychopharmcol,1995, 10 (suppl2) : 107~118 被引量:1
  • 3[2]De Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacol, 1995, 10(suppl4) : 19~23 被引量:1
  • 4[3]Stahl S, Zivkov M, Reimitz PE, et al. Meta-analysis of randomized,double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression. Acta Psychiatr Scand (suppl), 1997, 391 : 22~30 被引量:1
  • 5[4]Leinonen E, skarstein J, Behnke K, et al. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. Int Clin Psychopharmacol, 1999, 14 : 329~337 被引量:1
  • 6[5]Wheatley DP, Van Moffaert M, timmerman L, et al. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group. J Clin Psychiatry, 1998, 59: 306~312 被引量:1
  • 7[6]Kasper S. Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data. Int Clin Psychopharmacol, 1995, 10 (suppl 4) : 25~35 被引量:1
  • 8[7]Hoyberg OJ, Maragakis B, Mullin J, et al. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients. Acta Psycho Scand, 1996, 93 : 184~190 被引量:1
  • 9[8]Benkert O, Szegedi A, Kohnen R. Mirtazapine compared with paroxetine in major depression. J Clin Psychiatry, 2000 Sep, 61 (9) : 656~663 被引量:1
  • 10[9]Goodnick PJ, Puig A, DeVane CL, et al. Mirtazapine in major depression with comorbid generalized anxiety disorder. J Clin Psychiatry, 1999 Jul, 60(7) : 446~448 被引量:1

共引文献106

同被引文献12

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部